Saba Azarnoush

506 total citations
10 papers, 207 citations indexed

About

Saba Azarnoush is a scholar working on Hematology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Saba Azarnoush has authored 10 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 4 papers in Immunology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Saba Azarnoush's work include Acute Myeloid Leukemia Research (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Immune Cell Function and Interaction (3 papers). Saba Azarnoush is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Immune Cell Function and Interaction (3 papers). Saba Azarnoush collaborates with scholars based in France, Algeria and Belgium. Saba Azarnoush's co-authors include Sophie Caillat‐Zucman, Olivier Lantz, Marie Tourret, Marion Lambert, Jean‐Hugues Dalle, D. Guimber, Bénedicte Bruno, D. Séguy, Laurent Béghin and Brigitte Nelken and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Allergy and Clinical Immunology and British Journal of Haematology.

In The Last Decade

Saba Azarnoush

9 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saba Azarnoush France 7 120 39 37 35 35 10 207
Richard Powell United Kingdom 5 185 1.5× 26 0.7× 46 1.2× 58 1.7× 9 0.3× 7 312
Nora Bachmayer Sweden 5 158 1.3× 10 0.3× 53 1.4× 13 0.4× 7 0.2× 5 235
Suelen Martins Perobelli Brazil 5 75 0.6× 8 0.2× 7 0.2× 25 0.7× 42 1.2× 8 161
Jowita Frączkiewicz Poland 8 23 0.2× 8 0.2× 27 0.7× 71 2.0× 60 1.7× 34 185
Guy Aumais Canada 6 57 0.5× 12 0.3× 7 0.2× 14 0.4× 9 0.3× 11 146
Nienke J.E. Haverkate Netherlands 5 59 0.5× 7 0.2× 9 0.2× 38 1.1× 46 1.3× 8 177
Sarah K. Wideman United Kingdom 4 46 0.4× 20 0.5× 3 0.1× 20 0.6× 31 0.9× 6 119
Hamid Reza Razzaghian Canada 7 37 0.3× 15 0.4× 34 0.9× 9 0.3× 4 0.1× 9 190
Lilian F. de Ruiter Netherlands 8 91 0.8× 18 0.5× 4 0.1× 13 0.4× 7 0.2× 9 293
Anja Leiber Germany 9 290 2.4× 19 0.5× 13 0.4× 28 0.8× 6 0.2× 11 377

Countries citing papers authored by Saba Azarnoush

Since Specialization
Citations

This map shows the geographic impact of Saba Azarnoush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saba Azarnoush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saba Azarnoush more than expected).

Fields of papers citing papers by Saba Azarnoush

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saba Azarnoush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saba Azarnoush. The network helps show where Saba Azarnoush may publish in the future.

Co-authorship network of co-authors of Saba Azarnoush

This figure shows the co-authorship network connecting the top 25 collaborators of Saba Azarnoush. A scholar is included among the top collaborators of Saba Azarnoush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saba Azarnoush. Saba Azarnoush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hoshino, Akihiro, Sophia Polychronopoulou, Charikleia Kelaïdi, et al.. (2024). Loss-of-phosphorylation of IKZF1 results in gain-of-function associated with immune dysregulation. Journal of Allergy and Clinical Immunology. 154(1). 229–236.e2. 2 indexed citations
2.
Strullu, Marion, Arnaud Petit, Marlène Pasquet, et al.. (2022). Single‐dose (4.5 mg/m2) gemtuzumab ozogamicin in combination with fludarabine, cytarabine and anthracycline as reinduction therapy in relapsed or refractory paediatric acute myeloid leukaemia. British Journal of Haematology. 198(2). 373–381. 10 indexed citations
3.
Tourret, Marie, Marion Lambert, Mathieu F. Chevalier, et al.. (2021). Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy. Journal for ImmunoTherapy of Cancer. 9(10). e003123–e003123. 23 indexed citations
5.
Pennamen, Perrine, Angèle Tingaud‐Sequeira, Vincent Michaud, et al.. (2020). Novel variants in the BLOC1S3 gene in patients presenting a mild form of Hermansky–Pudlak syndrome. Pigment Cell & Melanoma Research. 34(1). 132–135. 7 indexed citations
6.
Toubiana, Julie, Saba Azarnoush, Valérie Bouchez, et al.. (2019). Bordetella parapertussis Bacteremia: Clinical Expression and Bacterial Genomics. Open Forum Infectious Diseases. 6(4). ofz122–ofz122. 8 indexed citations
7.
Couturier, M., Saba Azarnoush, Stéphane Girault, et al.. (2018). Seconde allogreffe : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bulletin du Cancer. 106(1). S40–S51. 2 indexed citations
8.
Tourret, Marie, Marion Salou, Liana Ghazarian, et al.. (2018). Ontogeny of human mucosal-associated invariant T cells and related T cell subsets. The Journal of Experimental Medicine. 215(2). 459–479. 100 indexed citations
9.
Azarnoush, Saba, Bénedicte Bruno, Laurent Béghin, et al.. (2012). Enteral nutrition: a first option for nutritional support of children following allo-SCT?. Bone Marrow Transplantation. 47(9). 1191–1195. 46 indexed citations
10.
Azarnoush, Saba, O. Carpentier, C. Thumerelle, et al.. (2010). Histiocytose langerhansienne néonatale. Archives de Pédiatrie. 17(11). 1583–1585.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026